Related Experiment Video

Updated: Aug 31, 2025

Noninvasive Monitoring of Lesion Size in a Heterologous Mouse Model of Endometriosis
08:16

Noninvasive Monitoring of Lesion Size in a Heterologous Mouse Model of Endometriosis

Published on: February 26, 2019

8.3K

Novel pharmacological therapies for the treatment of endometriosis

Laura Buggio1, Dhouha Dridi1, Giussy Barbara1,2

  • 1Gynecology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Expert Review of Clinical Pharmacology
|August 24, 2022
PubMed
Abstract

Insights

New pharmacological treatments for endometriosis are emerging, focusing on GnRH antagonists as second-line options. Research continues to seek ideal therapies for this chronic inflammatory disease impacting women's health.

Area of Science:

  • Reproductive medicine and endocrinology.
  • Gynecological inflammatory diseases.

Background:

  • Endometriosis is a chronic, estrogen-dependent inflammatory condition.
  • It causes pelvic pain, infertility, and impacts sexual function and psychological well-being.
  • Tailored patient management is crucial for effective endometriosis treatment.

Purpose of the Study:

  • To review the latest advancements in the pharmacological management of endometriosis.
  • To discuss the roles of GnRH antagonists, SPRMs, and SERMs.
  • To identify optimal therapeutic strategies for women with endometriosis.

Main Methods:

  • A narrative review of current literature.
  • Literature search conducted in PubMed and Embase databases.
  • Selection of high-quality, recent original articles and reviews.

Main Results:

  • Medical therapy is central to endometriosis management, with limited recent advances.
  • GnRH antagonists show efficacy and safety, particularly as second-line treatments.
  • Further research is necessary to determine ideal endometriosis treatments.

Conclusions:

  • GnRH antagonists are valuable second-line options for specific endometriosis cases.
  • Continued investigation is vital for developing superior therapeutic approaches.
  • Personalized treatment strategies are essential for managing endometriosis effectively.
Keywords:
GnRH antagonistSERMSPRMelagolixendometriosislinzagolixrelugolix

More Related Videos

Mouse Model of Surgically-induced Endometriosis by Auto-transplantation of Uterine Tissue08:02

Mouse Model of Surgically-induced Endometriosis by Auto-transplantation of Uterine Tissue

Published on: January 6, 2012

28.9K
Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma11:29

Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma

Published on: January 22, 2022

14.4K

Related Concept Videos

Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
175
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
304
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
316
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
278
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
221
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
139